On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP) in ...

Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...

Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r ...

Gastric cancer, the fifth most common malignancy worldwide and the fifth most common cause of cancer-related death, is ...

Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo therapies, today announced U.S ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

Report a crime tip Crime tips can be reported on the Mizzou Safe app or by calling MUPD at 573-882-7201. In-app crime tips ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...

Precision oncology, according to the National Institutes of Health (NIH), is a type of treatment in which doctors select ...

The Grand National Tour began April 19 in Minneapolis, and SZA and Lamar performed largely together, interspersed with solo ...

Qorvo achieves $869M revenue, driven by iPhone RF growth & diverse markets like automotive & defense. Find out more about its ...